Alterations in Postprandial Glucose and Lipid Metabolism in Patients With Obstructive Sleep Apnea
Examination of Association Between Glucose, Lipid Metabolism and Obstructive Sleep Apnea
1 other identifier
interventional
58
1 country
1
Brief Summary
The purpose of this study is to examine postprandial glucose and lipid metabolism in patients with obstructive sleep apnea.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2009
CompletedFirst Posted
Study publicly available on registry
July 20, 2009
CompletedStudy Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedMarch 6, 2012
March 1, 2012
2.2 years
July 17, 2009
March 5, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postprandial metabolic markers including glucose, cholesterol, triglyceride, ghrelin, leptin
baseline and 3 months after CPAP
Secondary Outcomes (7)
respiratory events (ie. apnea-hypopnea index)
baseline and 3 months after CPAP
inflammatory biomarkers (ie. IL-6, CRP)
baseline and 3 months after CPAP
quality of life
baseline and 3 months after CPAP
sleep quality
baseline and 3 months after CPAP
sympathetic activity in urine
baseline and 3 months after CPAP
- +2 more secondary outcomes
Study Arms (1)
CPAP
EXPERIMENTALInterventions
maintains upper airway patency and minimizes the obstructive events
Eligibility Criteria
You may qualify if:
- Subjects on admission for sleep study under the Respiratory Care and Sleep Control Medicine, Kyoto University Hospital.
- Subjects diagnosed with OSA (apnea hypopnea index \>=5/hour) by overnight polysomnography.
You may not qualify if:
- Subjects treating for acute infections or malignancy.
- Subjects with severe anemia, diabetes,and renal failure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kyoto University Graduate School of Medicine
Kyoto, Kyoto, 6068507, Japan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kazuo Chin, MD,PhD
Kyoto University, Graduate School of Medicine
- PRINCIPAL INVESTIGATOR
Yuichi Chihara, MD,PhD
Kyoto University, Graduate School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor
Study Record Dates
First Submitted
July 17, 2009
First Posted
July 20, 2009
Study Start
September 1, 2009
Primary Completion
December 1, 2011
Study Completion
March 1, 2012
Last Updated
March 6, 2012
Record last verified: 2012-03